Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Abstract

Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02668-y, published online 17 November 2023